Persistent binding of 3-methylcholanthrene to mouse lung DNA and its correlation with susceptibility to pulmonary

Cancer Research
|July 1, 1979
PubMed

Insights

Different mouse strains show varying susceptibility to polycyclic aromatic hydrocarbon-induced lung tumors. DNA adducts in lung tissue correlate with tumor development, while liver adducts are transient and uncharacterized.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Molecular Biology

Background:

  • Polycyclic aromatic hydrocarbons (PAHs) are environmental carcinogens.
  • Mouse strains exhibit differential susceptibility to PAH-induced pulmonary neoplasia.
  • Liver tissues are generally resistant to PAH carcinogenicity, unlike lung tissues.

Purpose of the Study:

  • To investigate the formation and persistence of PAH-DNA adducts in different mouse strains and tissues.
  • To correlate DNA adduct levels with susceptibility to lung cancer induced by PAHs.
  • To characterize the nature of PAH-DNA adducts in lung and liver tissues.

Main Methods:

  • Intravenous injection of radiolabeled 3-methylcholanthrene (a PAH) into A/J, C3H/HeJ, DBA/2J, and C57BL/6J mice.
  • DNA extraction from lung and liver tissues at various time points post-injection.
  • Digestion of DNA to deoxyribonucleosides and chromatographic separation using Sephadex LH-20.
  • Quantification of radiolabeled nucleoside-bound adducts.

Main Results:

  • Radiolabeled PAH adducts were detected in both lung and liver DNA across all mouse strains.
  • Adduct levels varied significantly between tissues and strains, with A/J lung showing the highest amounts.
  • Liver DNA adducts became undetectable by 28 days, while lung adducts persisted but were reduced.
  • Uncharacterized radioactivity eluted early from Sephadex LH-20, predominantly in liver samples, suggesting non-carcinogenic lesions.

Conclusions:

  • Lung DNA adduct levels in mice correlate with susceptibility to PAH-induced pulmonary neoplasia.
  • Transient and potentially non-carcinogenic adducts are formed in the liver.
  • Further characterization of uncharacterized radiolabeled material is needed to understand PAH metabolism and toxicity.